Effects of levonorgestrel-releasing intra-uterine system on the expression of vascular endothelial growth factor and adrenomedullin in the endometrium in adenomyosis (PDF)
Laoag-Fernandez,Jovelle B.; Maruo,Takeshi; Pakarinen,Paivi; Spitz,Irving M.; Johansson,Elof D.B.
Human Reproduction 18(4): 694-699
Publication date: 2003
The levonorgestrel-releasing intra-uterine system(LNg-IUS) has been used to control menorrhagia, but irregularbleeding during the first 3 months of use was the most notableside effect. Endometrial angiogenesis is believed to be regulatedby angiogenic factors. The study aim was to evaluate the effectsof LNg-IUS on vascular endothelial growth factor (VEGF) andadrenomedullin (AM) expression in the endometrium.
VEGF and AM expression were analysed using the avidin-biotinimmunoperoxidase method on endometrial curettage specimens frommenorrhagic women associated with adenomyosis before and 3 monthsafter LNg-IUS insertion.
VEGF expression was abundantboth in the endometrial glands and stroma before LNg-IUS insertion,but became scanty 3 months after insertion. No immunostainingfor AM was noted in the endometrial glands and stroma beforeLNg-IUS insertion, whereas AM immunostaining became prominentin the endometrial glands and stroma 3 months after LNg-IUSuse.
This is the first study to demonstrate thatLNg-IUS insertion results in decreased expression of VEGF andincreased expression of AM in the endometrial glands and stromaafter 3 months of use. The results obtained suggest that theincrease in AM expression in the endometrium may be responsiblefor the frequent occurrence of irregular bleeding during theinitial 3 months of LNg-IUS use.
For 60 years, the Population Council has changed the way the world thinks about important health and development issues. Explore an interactive timeline of the Council's history, learn more about some of our key contributions, and watch a short video about why your support is so important to us.